ARTICLE | Company News
Acacia Biosciences Inc., Rosetta deal
February 8, 1999 8:00 AM UTC
Rosetta will acquire Acacia in a stock transaction. Rosetta plans to integrate Acacia's Genome Reporter Matrix technology, which profiles the impact of a drug candidate on multiple gene pathways, into...